Beyond Drug Discovery
Dataset Analysis
Generative molecular design is shaped by simple proxy benchmarks for drug-like properties and models pretrained on large pharmaceutical datasets. This combination yields strong benchmark metrics but limits transferability to domains structu...
Provenance
Collected from papers.
Derived from paper: Beyond Drug Discovery: The Nanotechnology Molecular Optimization (NMO) Benchmark